We are monitoring the impact of COVID-19 on Latin America Active Pharmaceutical Ingredients Market Get in touch with us for detailed analysis Know More
Pulished Date May, 2021
ID: 11566
Share on
Share on

Latin America Active Pharmaceutical Ingredients Market Analysis Report – Segmented By Type of Manufacturing Process, Type of Synthesis, API Formulation, Application, Molecules & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) – Industry Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: May, 2021
ID: 11566
Pages: 90

Latin America Active Pharmaceutical Ingredients Market Size (2021 to 2026)

The Latin America Active Pharmaceutical Ingredients Market size is forecasted to be growing at a healthy CAGR during the forecast period.

The active pharmaceutical ingredients market is one of the lucrative and fast-growing markets in the domain of the pharma industry. Latin American API market is one of the markets that is registering a higher CAGR year on year. The market's major drivers are the rising geriatric population, increased expenditure on health, increased R&D investments in the pharma industry, rise in chronic diseases, less utilization of generic drugs, and government policy towards the API industry.

In Latin America, 52% of the population is geriatric, and they are aged above 60 years; this results in chronic diseases like cardiovascular disorders and diabetes. Moreover, with the less penetration of generic drugs, increased expenditure on health by the people contributing a lot to the market growth. Increased R&D expenditure in pharmaceutical production and govt policy on the API industry is also propelling the growth in the market of API. Moreover, with the use of APIs in drug manufacturing, the disease-causing cells can be targeted easily without disturbing the adjoining healthy cells and tissues. This is one of the major drivers for oral medicine and chemotherapy in the case of cancer patients.

The main restraints of the API market in the case of Latin America can be attributed to many factors such as delay in regulatory approvals, less development of pharma sector, extreme protocols for testing, API’s outsourcing, high investments for manufacturing, and less presence of manufacturing companies.

In Latin America, science and technology development is far behind when compared with other developed countries. So, the inordinate delay in the testing and application of APIs inhibits the market to a large extent. Apart from this, as there is a huge population living near the poverty line, they find API’s infused drugs to be more costly and relying solely on generic drugs, which is restraining the market for further expansion. API’s manufacturing usually requires highly sophisticated manufacturing units, so the pharma companies in these countries outsource the APIs from countries like China and India to minimize the costs. This is one of the major factors that are restraining the growth in the API market in Latin America.

Impact of COVID-19 on the Latin American API market:

Due to the ongoing pandemic created by COVID-19, there is a huge disruption in supply chains, and china being the epicenter for both viruses and APIs. The lain American region faced a severe shortage in importing the APIs. It made the countries in this region look for other markets like India and the US. COVID-19 has positively impacted the APIs Pharma industry of Latin America; the aftermath of the sudden lockdowns and restrictions, there is increased research being carried out in these countries for making efficient drugs for making medicines that can treat the comorbidities and associated complications of COVID-19. 

This research report on the Latin America active pharmaceutical ingredients market has been segmented and sub-segmented into the following categories.

By Type of Manufacturing Process:

  • Captive Manufacturing
  • Contract Manufacturing

By Type of Synthesis:

  • Synthetic
  • Biotech

By API Formulation:

  • Generic API
  • Innovative API

By Application:

  • Cardiovascular Diseases
  • Oncology
  • Neurological Disorders
  • Orthopedic Disorders
  • Respiratory
  • Gastrointestinal Disorders
  • Urology
  • Others

By Molecule:

  • Large Molecule
  • Small Molecule

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The APIs market of the Latin American region is mainly driven by the countries like Brazil, Argentina, and chile. All these countries follow different regulatory practices. Brazil is expected to become a pharmaceutical manufacturing hub for the Latin America region due to the fewer regulatory approvals and conformance to the procedures of all the countries in the region. Brazil’s generic drug sector is valued at USD 5.25 billion, which is expected to grow at a CAGR of 5%. Argentina and Chile have decided to acquire self-sufficiency in making APIs avoid supply chain disruptions in testing times like Covid 19. These countries in the region are trying to incentivize the captive manufacturing markets for API production. This is contributing a lot to the market expansion in the region.

KEY MARKET PLAYERS:

Major companies operating in the Latin American active pharmaceutical ingredients profiled in this report are AbbVie Inc., AstraZeneca, Aurobindo Pharma Ltd., BASF, Bayer AG, Boehringer Ingelheim, Dr. Reddy's Laboratories, F. Hoffmann-La Roche, GlaxoSmithKline plc, Lonza Group, Lupin Limited, Merck & Co., Inc., Mylan NV, Novartis International AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type of Manufacturing Process
      1. Captive Manufacturing
      2. Contract Manufacturing
      3. Y-o-Y Growth Analysis, By Manufacturing Process
      4. Market Attractiveness Analysis, By Manufacturing Process
      5. Market Share Analysis, By Manufacturing Process
    2. By Type of Synthesis
      1. Synthetic
      2. Biotech
      3. Y-o-Y Growth Analysis, By Type of Synthesis
      4. Market Attractiveness Analysis, By Type of Synthesis
      5. Market Share Analysis, By Type of Synthesis
    3. By API Formulation
      1. Generic API
      2. Innovative API
      3. Y-o-Y Growth Analysis, By API Formulation
      4. Market Attractiveness Analysis, By API Formulation
      5. Market Share Analysis, By API Formulation
    4. By Application
      1. Cardiovascular Diseases
      2. Oncology
      3. Neurological Disorders
      4. Orthopedic Disorders
      5. Respiratory
      6. Gastrointestinal Disorders
      7. Urology
      8. Others
      9. Y-o-Y Growth Analysis, By Application
      10.  Market Attractiveness Analysis, By Application
      11.  Market Share Analysis, By Application
    5. By Molecule
      1. Large Molecule
      2. Small Molecule
      3. Y-o-Y Growth Analysis, By Molecule
      4. Market Attractiveness Analysis, By Molecule
      5. Market Share Analysis, By Molecule
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
    2. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Sanofi
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Bayer AG
    3. Pfizer Inc.
    4. F. Hoffmann-La Roche AG
    5. Abbott Laboratories
    6. Merck & Co., Inc.
    7. Boehringer Ingelheim GmbH
    8. Glaxosmithkline Plc (GSK)
    9. Novartis AG
    10. Eli Lilly and Company
    11. Teva Pharmaceutical Industries Ltd
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the regions that are still untapped.
  • The segment-level analysis in terms of the type of manufacturing process, type of synthesis, API formulation, application, molecules along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market, which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturing process, From 2021 to 2026 (USD Million)
  2. Latin America Captive Manufacturing Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Contract Manufacturing Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, From 2021 to 2026 (USD Million)
  5. Latin America Synthetic Market, By Region, From 2021 to 2026 (USD Million)
  6. Latin America Biotech Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Active Pharmaceutical Ingredients Market, By API Formulation, From 2021 to 2026 (USD Million)
  8. Latin America Generic API Market, By Region, From 2021 to 2026 (USD Million)
  9. Latin America Innovative API Market, By Region, From 2021 to 2026 (USD Million)
  10. Latin America Active Pharmaceutical Ingredients Market, By Application, From 2021 to 2026 (USD Million)
  11. Latin America Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Million)
  12. Latin America Oncology Market, By Region, From 2021 to 2026 (USD Million)
  13. Latin America Neurological Disorders Market, By Region, From 2021 to 2026 (USD Million)
  14. Latin America Orthopaedic Disorders Market, By Region, From 2021 to 2026 (USD Million)
  15. Latin America Respiratory Market, By Region, From 2021 to 2026 (USD Million)
  16. Latin America Gastrointestinal Disorders Market, By Region, From 2021 to 2026 (USD Million)
  17. Latin America Urology Market, By Region, From 2021 to 2026 (USD Million)
  18. Latin America Others Market, By Region, From 2021 to 2026 (USD Million)
  19. Latin America Active Pharmaceutical Ingredients Market, By Molecule, From 2021 to 2026 (USD Million)
  20. Latin America Large Molecule Market, By Region, From 2021 to 2026 (USD Million)
  21. Latin America Small Molecule Market, By Region, From 2021 to 2026 (USD Million)
  22. Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturing process, From 2021 to 2026 (USD Million)
  23. Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, From 2021 to 2026 (USD Million)
  24. Brazil Active Pharmaceutical Ingredients Market, By API Formulation, From 2021 to 2026 (USD Million)
  25. Brazil Active Pharmaceutical Ingredients Market, By Application, From 2021 to 2026 (USD Million)
  26. Brazil Active Pharmaceutical Ingredients Market, By Molecule, From 2021 to 2026 (USD Million)
  27. Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturing process, From 2021 to 2026 (USD Million)
  28. Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, From 2021 to 2026 (USD Million)
  29. Argentina Active Pharmaceutical Ingredients Market, By API Formulation, From 2021 to 2026 (USD Million)
  30. Argentina Active Pharmaceutical Ingredients Market, By Application, From 2021 to 2026 (USD Million)
  31. Argentina Active Pharmaceutical Ingredients Market, By Molecule, From 2021 to 2026 (USD Million)
  32. Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturing process, From 2021 to 2026 (USD Million)
  33. Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, From 2021 to 2026 (USD Million)
  34. Mexico Active Pharmaceutical Ingredients Market, By API Formulation, From 2021 to 2026 (USD Million)
  35. Mexico Active Pharmaceutical Ingredients Market, By Application, From 2021 to 2026 (USD Million)
  36. Mexico Active Pharmaceutical Ingredients Market, By Molecule, From 2021 to 2026 (USD Million)
  37. Rest of Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturing process, From 2021 to 2026 (USD Million)
  38. Rest of Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, From 2021 to 2026 (USD Million)
  39. Rest of Latin America Active Pharmaceutical Ingredients Market, By API Formulation, From 2021 to 2026 (USD Million)
  40. Rest of Latin America Active Pharmaceutical Ingredients Market, By Application, From 2021 to 2026 (USD Million)
  41. Rest of Latin America Active Pharmaceutical Ingredients Market, By Molecule, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample